Literature DB >> 16648340

Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study.

Declan G M Murphy1, Eileen Daly, Nicole Schmitz, Fiona Toal, Keiran Murphy, Sarah Curran, Kjell Erlandsson, Jos Eersels, Robert Kerwin, Peter Ell, Michael Travis.   

Abstract

OBJECTIVE: The cause of autistic spectrum disorder (i.e., autism and Asperger's syndrome) is unknown. The serotonergic (5-HT) system may be especially implicated. However, cortical 5-HT2A receptor density in adults with the disorder has not been examined, to the authors' knowledge.
METHOD: The authors investigated cortical 5-HT2A receptor binding in eight adults with Asperger's syndrome and in 10 healthy comparison subjects with single photon emission computed tomography and the selective 5-HT2A receptor ligand 123I iodinated 4-amino-N-[1-[3-(4-fluorophenoxy)propyl]-4-methyl-4-piperidinyl]-5-iodo-2-methoxybenzamide (123I-5-I-R91150).
RESULTS: People with Asperger's syndrome had a significant reduction in cortical 5-HT2A receptor binding in the total, anterior, and posterior cingulate; bilaterally in the frontal and superior temporal lobes; and in the left parietal lobe. Also, reduced receptor binding was significantly related to abnormal social communication.
CONCLUSIONS: The authors' findings suggest that adults with Asperger's syndrome have abnormalities in cortical 5-HT2A receptor density and that this deficit may underlie some clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648340     DOI: 10.1176/ajp.2006.163.5.934

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  49 in total

Review 1.  Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research.

Authors:  Ayesha C Sujan; A Sara Öberg; Patrick D Quinn; Brian M D'Onofrio
Journal:  J Child Psychol Psychiatry       Date:  2018-12-05       Impact factor: 8.982

2.  The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASB.

Authors:  Ragy R Girgis; Mark Slifstein; Xiaoyan Xu; W Gordon Frankle; Evdokia Anagnostou; Stacey Wasserman; Lauren Pepa; Alexander Kolevzon; Anissa Abi-Dargham; Marc Laruelle; Eric Hollander
Journal:  Psychiatry Res       Date:  2011-11-12       Impact factor: 3.222

Review 3.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

4.  Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems.

Authors:  Elizabeth Hammock; Jeremy Veenstra-VanderWeele; Zhongyu Yan; Travis M Kerr; Marianna Morris; George M Anderson; C Sue Carter; Edwin H Cook; Suma Jacob
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-05-26       Impact factor: 8.829

5.  Whole Blood Serotonin Levels and Platelet 5-HT2A Binding in Autism Spectrum Disorder.

Authors:  Elizabeth Aaron; Alicia Montgomery; Xinguo Ren; Stephen Guter; George Anderson; Ana M D Carneiro; Suma Jacob; Matthew Mosconi; Ghanshyam N Pandey; Edwin Cook; Jeremy Veenstra-VanderWeele
Journal:  J Autism Dev Disord       Date:  2019-06

6.  Family-based clinical associations and functional characterization of the serotonin 2A receptor gene (HTR2A) in autism spectrum disorder.

Authors:  Ryan M Smith; Wesley Banks; Emily Hansen; Wolfgang Sadee; Gail E Herman
Journal:  Autism Res       Date:  2014-04-17       Impact factor: 5.216

Review 7.  The serotonin system in autism spectrum disorder: From biomarker to animal models.

Authors:  C L Muller; A M J Anacker; J Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

8.  Rigid-compulsive behaviors are associated with mixed bowel symptoms in autism spectrum disorder.

Authors:  Brittany Peters; Kent C Williams; Phillip Gorrindo; Daniel Rosenberg; Evon Batey Lee; Pat Levitt; Jeremy Veenstra-VanderWeele
Journal:  J Autism Dev Disord       Date:  2014-06

9.  The serotonergic system: its role in pathogenesis and early developmental treatment of autism.

Authors:  D I Zafeiriou; A Ververi; E Vargiami
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

10.  Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouse.

Authors:  Jeremy Veenstra-Vanderweele; Tammy N Jessen; Brent J Thompson; Michelle Carter; Harish C Prasad; Jennifer A Steiner; James S Sutcliffe; Randy D Blakely
Journal:  J Neurodev Disord       Date:  2009-06       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.